Physician profile
Kelly M Stephens
NPI 1588113831
$676.70
in general payments reported to CMS, 2019-2025
14 companies · $58.63 in 2025
The $58.63 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $472 · 2022: $15.43 · 2023: $74.97 · 2024: $55.62 · 2025: $58.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168 · Education: $21.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.58 |
| Education | $21.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $120.99 | 2021 | |
| Abbvie INC. | $107.51 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $89.61 | 2021 | |
| Eisai INC. | $78.40 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.61 | 2021-2022 | |
| Boston Scientific Corporation | $40.44 | 2021-2023 | Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $40.40 | 2021-2023 | Invega Sustenna |
| Lundbeck LLC | $35.44 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $28.37 | 2021 | |
| Curonix LLC | $21.64 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Corium, LLC | $20.04 | 2024 | Azstarys |
| Vanda Pharmaceuticals INC. | $19.53 | 2021 | |
| Bausch Health US, LLC | $16.20 | 2021 | |
| Alkermes, INC. | $14.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.